Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
GlaxoSmithKline
GlaxoSmithKline
Washington University School of Medicine
GlaxoSmithKline
Tesaro, Inc.
Elevation Oncology
Tesaro, Inc.
University of Southern California
GlaxoSmithKline